SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
EXACT SCIENCES CORP
(NQSC:EXAS Last Sale: 77.43 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQSC: (EXAS : $77.43)
$11,457,124 million Market Cap at Market Close, July 1, 2022
Employs 50.
Biomedics SubIndustry up .00% / Health Industry up .00% Today
100 Campus Drive Research Report Earnings Snapshot - Last 10/27/18
Maynard, MA 01752 Fact Sheet
Phone: 508-683-1200 Financial Statements
Peer Comparison
Annual Reports

Stanley N. Lapidus, Founder, Don M. Hardison, CEO/Pres., Harry W. Wilcox III, CFO
March 2009, after rejected a buyout proposal from Sequenom Inc. of San Diego in favor of "pursuing a strategic alternative" and announced a $24.5 million strategic deal with Genzyme Corp. Develops proprietary technologies in applied genomics. IPO at $14 January 30, 2001. Raised $56 million, selling 4 million shares, 21% of the outstanding. Lead Manager: Merrill Lynch.
Historical Charts    Technical Analysis
No Historical Data available for EXAS

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common EXAS $77.43 $77.43 0 .0 $73.11 $77.44 1,572,226 $73.11 $77.44 147,967,507
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10126
Common Stock #############

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2025 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex